Status:
COMPLETED
The Effects of Vasopressin on Attention Control
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
The main aim of the present study is to investigate whether intranasal vasopressin (20IU) could influence attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.
Detailed Description
A number of previous studies have reported vasopressin's effect on human social behavior and social cognition, although it remains unclear whether vasopressin could modulate attention allocation inclu...
Eligibility Criteria
Inclusion
- Healthy participants
- Non smokers
Exclusion
- Previous or current medical, psychiatric, neurological disorder
- Regular medication
- Use of any psychoactive substances in the 24 hours before experiment
- Contra-indications for vasopressin
- Contra-indications for eye-tracking data acquisition
Key Trial Info
Start Date :
July 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT04493554
Start Date
July 28 2020
End Date
January 1 2021
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China, 611731